Neuropeptide Y receptor-specifically modulates human neutrophil function

Journal of Neuroimmunology

Volumn 195, Issue 1-2, 2008, Pages 88-95

  Bedoui, Sammy ^a,b,d   Kromer, Andreas ^a,d   Gebhardt, Thomas ^a,d   Jacobs, Roland ^a,d   Raber, Kerstin ^a,c,d   Dimitrijevic, Mirja ^c,d   Heine, Jörn ^a,d   von Hörsten, Stephan ^a,c,d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Immunology Division ^*  (Australia)

^c Inst of Immunol and Virol Torlak   (Serbia)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Human neutrophils; Neuroimmune interactions; Neuropeptide Y (NPY); NPY receptors; Phagocytosis; Reactive oxygen species

Indexed keywords

NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; REACTIVE OXYGEN METABOLITE;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; HUMAN; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HUMANS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUROPEPTIDE Y; NEUTROPHILS; PHAGOCYTOSIS; RADIOLIGAND ASSAY; REACTIVE OXYGEN SPECIES; RECEPTORS, NEUROPEPTIDE Y;

EID: 41949104683     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.01.012     Document Type: Article

References (32)

1. Aldridge A.J. Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur. J. Surg. 168 (2002) 204-214
2. Bedoui S., Kuhlmann S., Nave H., Drube J., Pabst R., and von Hörsten S. Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood: mobilization of B-1-like B-lymphocytes and activated monocytes. J. Neuroimmunol. 117 (2001) 125-132
3. Bedoui S., Lechner S., Gebhardt T., Nave H., Beck-Sickinger A.G., Straub R.H., Pabst R., and von Hörsten S. NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization. J. Neuroimmunol. 132 (2002) 25-33
4. Bedoui S., Lechner S., Gebhardt T., Nave H., Beck-Sickinger A.G., Straub R.H., Pabst R., and von Hörsten S. NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo: sympathetic co-transmission during leukocyte mobilization. J. Neuroimmunol. 132 (2002) 25-33
5. Bedoui S., Kawamura N., Straub R.H., Pabst R., Yamamura T., and von Hörsten S. Relevance of neuropeptide Y for the neuroimmune crosstalk. J. Neuroimmunol. 134 (2003) 1-11
6. Bedoui S., Miyake S., Lin Y., Miyamoto K., Oki S., Kawamura N., Beck-Sickinger A., von Hörsten S., and Yamamura T. Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo. J. Immunol. 171 (2003) 3451-3458
7. Bedoui S., Miyake S., Straub R.H., von Hörsten S., and Yamamura T. More sympathy for autoimmunity with neuropeptide Y?. Trends Immunol. 25 (2004) 508-512
8. Doods H., Gaida W., Wieland H.A., Dollinger H., Schnorrenberg G., Esser F., Engel W., Eberlein W., and Rudolf K. BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur. J. Pharmacol. 384 (1999) R3-R5
9. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52 (2000) 595-638
10. Fabry M., Cabrele C., Hocker H., and Beck-Sickinger A.G. Differently labeled peptide ligands for rapid investigation of receptor expression on a new human glioblastoma cell line. Peptides 21 (2000) 1885-1893
11. Fuhlendorff J., Gether U., Aakerlund L., Langeland-Johansen N., Thogersen H., Melberg S.G., Olsen U.B., Thastrup O., and Schwartz T.W. [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 182-186
12. Hafström I., Ringertz B., Lundeberg T., and Palmblad J. The effect of endothelin, neuropeptide Y, calcitonin gene-related peptide and substance P on neutrophil functions. Acta Physiol. Scand. 148 (1993) 341-346
13. Hauser G.J., Myers A.K., Dayao E.K., and Zukowska-Grojec Z. Neuropeptide Y infusion improves hemodynamics and survival in rat endotoxic shock. Am. J. Physiol. 265 (1993) H1416-H1423
14. Hwa J.J., Witten M.B., Williams P., Ghibaudi L., Gao J., Salisbury B.G., Mullins D., Hamud F., Strader C.D., and Parker E.M. Activation of the NPY Y5 receptor regulates both feeding and energy expenditure. Am. J. Physiol. 277 (1999) R1428-R1434
15. Kawamura N., Tamura H., Obana S., Wenner M., Ishikawa T., Nakata A., and Yamamoto H. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 5 (1998) 9-15
16. Kohm A.P., and Sanders V.M. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 53 (2001) 487-525
17. Levite M., and Chowers Y. Nerve-driven immunity: neuropeptides regulate cytokine secretion of T cells and intestinal epithelial cells in a direct, powerful and contextual manner. Ann. Oncol. 12 Suppl 2 (2001) S19-S25
18. Lundberg J.M., Martinsson A., Hemsen A., Theodorsson-Norheim E., Svedenhag J., Ekblom B., and Hjemdahl P. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem. Biophys. Res. Commun. 133 (1985) 30-36
19. Marshall G.D. Neuroendocrine mechanisms of immune dysregulation: applications to allergy and asthma. Ann. Allergy Asthma Immun. 93 (2004) S11-S17
20. Michel M.C., Beck-Sickinger A., Cox H., Doods H.N., Herzog H., Larhammar D., Quirion R., Schwartz T., and Westfall T. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 50 (1998) 143-150
21. Nave H., Bedoui S., Moenter F., Steffens J., Felies M., Gebhardt T., Straub R.H., Pabst R., Dimitrijevic M., Stanojevic S., and von Hörsten S. Reduced tissue immigration of monocytes by neuropeptide Y during endotoxemia is associated with Y2 receptor activation. J. Neuroimmunol. 155 (2004) 1-12
22. Petitto J.M., Huang Z., and McCarthy D.B. Molecular cloning of NPY-Y1 receptor cDNA from rat splenic lymphocytes: evidence of low levels of mRNA expression and [125I]NPY binding sites. J. Neuroimmunol. 54 (1994) 81-86
23. Quinn M.T., and Gauss K.A. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J. Leukoc. Biol. 76 (2004) 760-781
24. Qureshi N.U., Dayao E.K., Shirali S., Zukowska-Grojec Z., and Hauser G.J. Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock. Regul. Pept. 75-76 (1998) 215-220
25. Schwartz T.W., Sheikh S.P., and O'Hare M.M. Receptors on phaeochromocytoma cells for two members of the PP-fold family-NPY and PP. FEBS Lett. 225 (1987) 209-214
26. Schwarz H., Villiger P.M., von Kempis J., and Lotz M. Neuropeptide Y is an inducible gene in the human immune system. J. Neuroimmunol. 51 (1994) 53-61
27. Sessler C.N., Perry J.C., and Varney K.L. Management of severe sepsis and septic shock. Curr. Opin. Crit. Care 10 (2004) 354-363
28. Straub R.H., Mayer M., Kreutz M., Leeb S., Schölmerich J., and Falk W. Neurotransmitters of the sympathetic nerve terminal are powerful chemoattractants for monocytes. J. Leukoc. Biol. 67 (2000) 553-558
29. Tatemoto K., Carlquist M., and Mutt V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296 (1982) 659-660
30. Tatemoto K., Siimesmaa S., Jornvall H., Allen J.M., Polak J.M., Bloom S.R., and Mutt V. Isolation and characterization of neuropeptide Y from porcine intestine. FEBS Lett. 179 (1985) 181-184
31. von Hörsten S., Ballof J., Helfritz F., Nave H., Meyer D., Schmidt R.E., Stalp M., Klemm A., Tschernig T., and Pabst R. Modulation of innate immune functions by intracerebroventricularly applied neuropeptide Y: dose and time dependent effects. Life Sci. 63 (1998) 909-922
32. Wieland H.A., Engel W., Eberlein W., Rudolf K., and Doods H.N. Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. Br. J. Pharmacol. 125 (1998) 549-555